Legal & General Group
BCAB icon

Legal & General Group’s BioAtla BCAB Stock Holding History

Legal & General Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85
Closed -$14.6K – 3422
2024
Q1 		$14.6K Hold
85
– – ﹤0.01% 3101
2023
Q4 		$10.4K Hold
85
– – ﹤0.01% 3229
2023
Q3 		$7.21K Hold
85
– – ﹤0.01% 3325
2023
Q2 		$12.7K Buy
+85
New +$14.6K ﹤0.01% 3271
2022
Q2 		– Sell
-123
Closed -$31K – 3532
2022
Q1 		$31K Buy
123
+2
+2% +$837 ﹤0.01% 3112
2021
Q4 		$119K Hold
121
– – ﹤0.01% 2873
2021
Q3 		$179K Buy
121
+96
+384% +$187K ﹤0.01% 2724
2021
Q2 		$54K Buy
25
+1
+4% +$2.26K ﹤0.01% 2923
2021
Q1 		$60K Buy
24
+4
+20% +$10.3K ﹤0.01% 2760
2020
Q4 		$34K Buy
+20
New +$33.4K ﹤0.01% 2903

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Legal & General Group's BCAB Position: Q2 2024 in Review

Legal & General Group sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 85 shares — an estimated $14.6K sold.

Legal & General Group first reported a position in BCAB in Q4 2020 and held it in 10 quarters. The position peaked at $179K in Q3 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Legal & General Group reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 85 BioAtla shares in Q2 2024, an estimated $14.6K.
  • Legal & General Group first reported a position in BioAtla in Q4 2020 and held it in 10 quarters.
  • Legal & General Group's BioAtla position peaked at $179K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.